Carbidopa/Entacapone/Levodopa

卡比多巴/恩他卡朋/左旋多巴

Report date: 2023/04/21 16:05:23

Base Information

Drug NameCarbidopa/Entacapone/Levodopa
Drug Alias Nameレボドパ・カルビドパ水和物・エンタカポンCarbidopa - Levodopa - Entacapone mixt卡比多巴恩他卡朋左旋多巴Entacapone-Levodopa-Carbidopa mixt恩他卡朋-左旋多巴-卡比多巴 +[20] 
ClassificationSmall molecules
Mechanisms of ActionDopamine receptors agonistsCatechol-O-methyl transferase inhibitorsDOPA decarboxylase inhibitors
TargetsCatechol-O-methyl transferaseAromatic-L-amino-acid decarboxylaseDopamine receptors
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsParkinson Disease
Approved Indications in ChinaParkinson Disease
Original Approved Country/TerritoryUnited States
Original Approved Date2003/06/11
Country/TerritoryBelgiumCanadaUnited States +[17] 
CombinationsYes EntacaponeLevodopaCarbidopa
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesOrion Pharma
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma AgOrion Pharma A/SOrion Corp
Inactive CompaniesOrion Corporation Orion Pharma
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN04BA03
Related LinksWikipediaKEGG